|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19,516.65 INR | -0.01% |
|
+3.17% | +28.48% |
| Market Cap | 250B 2.63B 2.3B 2.12B 1.96B 3.71B 3.77B 25.31B 9.94B 123B 9.86B 9.64B 424B | P/E 2026 |
42.3x | P/E 2027 * | 59.7x |
|---|---|---|---|---|---|
| Enterprise Value | 250B 2.62B 2.3B 2.12B 1.96B 3.71B 3.77B 25.3B 9.93B 123B 9.85B 9.64B 424B | EV / Sales 2026 |
7.59x | EV / Sales 2027 * | 11x |
| Free-Float |
62.24% | Yield 2026 |
0.28% | Yield 2027 * | 0.07% |
Last Transcript: Neuland Laboratories Limited
| 1 day | -0.01% | ||
| 1 week | +3.17% | ||
| Current month | +4.76% | ||
| 1 month | +15.13% | ||
| 3 months | +30.56% | ||
| 6 months | +32.08% | ||
| Current year | +28.48% |
| 1 week | 18,400 | 20,072 | |
| 1 month | 16,569.95 | 20,072 | |
| Current year | 11,500 | 20,072 | |
| 1 year | 11,500 | 20,072 | |
| 3 years | 2,871.4 | 20,072 | |
| 5 years | 965.85 | 20,072 | |
| 10 years | 247.3 | 20,072 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 46 | 01/04/2026 | |
Abhijit Majumdar
DFI | Director of Finance/CFO | - | 23/11/2022 |
Ajitabh Singh
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/08/2025 | |
| Director/Board Member | 80 | 31/10/2022 | |
| Director/Board Member | 82 | 12/02/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.01% | +3.17% | +58.59% | +550.82% | 2.63B | ||
| -2.33% | -2.09% | +49.88% | +170.51% | 1,060B | ||
| -0.82% | -2.30% | +63.79% | +62.00% | 619B | ||
| -0.73% | -4.98% | +28.91% | +82.99% | 438B | ||
| +0.33% | -1.17% | +31.07% | +27.09% | 333B | ||
| -0.02% | -2.85% | +29.15% | +45.24% | 282B | ||
| -3.89% | -11.22% | +22.81% | +27.30% | 267B | ||
| +0.66% | -1.42% | -26.59% | -37.71% | 218B | ||
| -0.06% | -2.88% | +23.07% | +62.33% | 196B | ||
| -3.72% | -1.10% | +18.41% | +70.56% | 161B | ||
| Average | -1.06% | -2.60% | +29.91% | +106.11% | 357.65B | |
| Weighted average by Cap. | -1.31% | -2.95% | +36.77% | +84.25% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 17.64B 185M 162M 149M 138M 261M 266M 1.78B 700M 8.69B 694M 679M 29.87B | 23.09B 242M 212M 195M 180M 342M 348M 2.33B 916M 11.37B 909M 889M 39.1B |
| Net income | 2.57B 26.97M 23.59M 21.76M 20.1M 38.14M 38.78M 260M 102M 1.27B 101M 99.08M 4.36B | 4.21B 44.13M 38.6M 35.61M 32.89M 62.4M 63.45M 425M 167M 2.07B 166M 162M 7.13B |
| Net Debt | -117M -1.22M -1.07M -986K -910K -1.73M -1.76M -11.78M -4.62M -57.4M -4.59M -4.49M -197M | 2.94B 30.8M 26.94M 24.85M 22.95M 43.55M 44.28M 297M 117M 1.45B 116M 113M 4.97B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | ₹19,516.65 | -0.01% | 1,586 |
| 09/07/26 | ₹19,519.45 | +3.53% | 3,876 |
| 08/07/26 | ₹18,854.00 | -0.29% | 2,572 |
| 07/07/26 | ₹18,908.70 | +0.26% | 1,093 |
| 06/07/26 | ₹18,858.95 | -0.30% | 976 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NEULANDLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















